| Previous close | 67.60 |
| Open | 67.60 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 140.00 |
| Expiry date | 2024-11-15 |
| Day's range | 67.60 - 67.60 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksMRNA Gets Positive CHMP Opinion for Updated COVID-19 Jab
The Committee for Medicinal Products for Human Use recommends marketing authorization for Moderna's updated mRNA COVID-19 jab, Spikevax.
Investor's Business DailyModerna Stock's Three-Year Decline — Is It Time To Sell, Hold Or Buy?
Despite becoming one a household name during the pandemic, Moderna stock has mostly fallen over the past three years amid slow sales.
ZacksNovavax Stock Up 9% on FDA Nod for Updated COVID-19 Vaccine
The FDA authorization for NVAX's updated COVID-19 vaccine makes it the only non-mRNA vaccine option in the country.
© 2024 Yahoo. All rights reserved.